SENATE DOCKET, NO. 756        FILED ON: 1/15/2015

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 513

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

John F. Keenan

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to risk classifications for medical liability insurance.

_______________

PETITION OF:

 

Name:

District/Address:

John F. Keenan

Norfolk and Plymouth


SENATE DOCKET, NO. 756        FILED ON: 1/15/2015

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 513

By Mr. Keenan, a petition (accompanied by bill, Senate, No. 513) of John F. Keenan for legislation  relative to risk classifications for medical liability insurance.  Financial Services.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Eighty-Ninth General Court
(2015-2016)

_______________

 

An Act relative to risk classifications for medical liability insurance.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1.  Section 193U of Chapter 175 of the General Laws, as appearing in the 2012 Official Edition, is hereby amended by inserting after the word “specialty” in line 13 the following:-

“, nor from establishing reasonable classifications of risk and premium charges based on a practitioners status with regard to enrollment in and utilization of the prescription monitoring program as established pursuant to section 24A of chapter 94C.”

SECTION 2. The commissioner of insurance shall promulgate regulations requiring that each carrier providing professional medical liability insurance, before issuing or renewing a policy with a practitioner who is required to enroll in the prescription monitoring program, as established pursuant to section 24A of chapter 94C, shall require from the practitioner a statement affirming their enrollment in said prescription monitoring program, and a statement from the practitioner affirming that they utilize said prescription monitoring program as required by the General Laws and by the regulations of the department of public health.